Palmoplantar Keratoderma in Costello Syndrome Responsive to Acitretin

Pediatr Dermatol. 2017 Mar;34(2):160-162. doi: 10.1111/pde.13057. Epub 2016 Dec 23.

Abstract

Costello syndrome (CS) is a multisystem congenital disorder characterized by coarse facial features, cardiac defects, intellectual disability, and predisposition to malignancies. Dermatologic findings can include cutaneous papillomas, skin redundancy, acanthosis nigricans, and keratosis pilaris. Palmoplantar keratoderma (PPK) is present in approximately 76% of patients with CS, with disabling functional consequences in severe cases. We report a case of CS with severe PPK that improved dramatically with systemic administration of acitretin 0.3 mg/kg/day.

Publication types

  • Case Reports

MeSH terms

  • Acitretin / therapeutic use*
  • Costello Syndrome / complications*
  • Costello Syndrome / pathology*
  • Female
  • Humans
  • Keratoderma, Palmoplantar / drug therapy*
  • Keratoderma, Palmoplantar / etiology*
  • Keratoderma, Palmoplantar / pathology
  • Keratolytic Agents / therapeutic use*
  • Young Adult

Substances

  • Keratolytic Agents
  • Acitretin